发现一种口服生物可用和脑透的选择性雌激素受体降解剂
Guobao Zhang1, Peter Q Huang1, Kevin D Bunker1
1Zentalis Pharmaceuticals, San Diego 92121, California, United States.
Journal of medicinal chemistry
|May 20, 2025
概括
研究人员开发了新的口服选择性雌激素受体降解剂 (SERDs),以增强大脑透. 这些化合物在乳腺癌患者治疗大脑转移方面显著有前途.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 药理学 药理学 是一个学科.
背景情况:
- 许多口服选择性雌激素受体降解剂 (SERD) 缺乏足够的中枢神经系统 (CNS) 透.
- 乳腺癌 (BCBM) 中的大脑转移代表了一个重要的未满足的医疗需求.
研究的目的:
- 发现和开发穿透大脑的口服SERD用于治疗乳腺癌大脑转移.
- 解决CNS透中现有的SERDs存在的局限性.
主要方法:
- 修改了ZN-c5结构,将烯酸图案替换为基本的氨基尾.
- 在体外和体内对化合物的疗效,ADME特性和大脑透的评估.
- 在脑转移乳腺癌的临床前模型中进行测试.
主要成果:
- 结构修改显著改善了大脑透和雌激素受体 (ER) 降解活性.
- 化合物5在体外和体内表现出极好的疗效.
- 化合物5在多种动物模型中表现出良好的口服生物可用性和卓越的大脑透.
结论:
- 成功开发了具有增强脑透力的新型口服SERD.
- 化合物5对患有乳腺癌脑转移的患者具有显著的治疗潜力.
- 开发的化合物代表了BCBM治疗的有希望的新策略.
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Drug Delivery: Enteral Route
394
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
394
Prodrugs
2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.5K


